{"id":"https://openalex.org/W1483095253","doi":"https://doi.org/10.1111/j.2040-1124.2011.00128.x","title":"Fifty-two-week, randomized, multicenter trial to compare the safety and efficacy of the novel glucagon-like peptide-1 analog liraglutide vs glibenclamide in patients with type 2 diabetes","display_name":"Fifty-two-week, randomized, multicenter trial to compare the safety and efficacy of the novel glucagon-like peptide-1 analog liraglutide vs glibenclamide in patients with type 2 diabetes","publication_year":2011,"publication_date":"2011-05-19","ids":{"openalex":"https://openalex.org/W1483095253","doi":"https://doi.org/10.1111/j.2040-1124.2011.00128.x","mag":"1483095253","pmid":"https://pubmed.ncbi.nlm.nih.gov/24843528","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4014903"},"language":"en","primary_location":{"id":"doi:10.1111/j.2040-1124.2011.00128.x","doi":"https://doi.org/10.1111/j.2040-1124.2011.00128.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.2040-1124.2011.00128.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.2040-1124.2011.00128.x","source":{"id":"https://openalex.org/S107365432","display_name":"Journal of Diabetes Investigation","issn_l":"2040-1116","issn":["2040-1116","2040-1124"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310322041","host_organization_name":"Asian Association for the Study of Diabetes","host_organization_lineage":["https://openalex.org/P4310322041"],"host_organization_lineage_names":["Asian Association for the Study of Diabetes"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Diabetes Investigation","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.2040-1124.2011.00128.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036190568","display_name":"Kohei Kaku","orcid":"https://orcid.org/0000-0003-1574-0565","observed_orcids":["https://orcid.org/0000-0003-1574-0565"]},"institutions":[{"id":"https://openalex.org/I189996419","display_name":"Kawasaki Medical School","ror":"https://ror.org/059z11218","country_code":"JP","type":"education","lineage":["https://openalex.org/I189996419"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kohei Kaku","raw_affiliation_strings":["Division of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Okayama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Okayama","institution_ids":["https://openalex.org/I189996419"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109247811","display_name":"Mads Frederik Rasmussen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Mads Frederik Rasmussen","raw_affiliation_strings":["Medical and Science, GLP-1, Novo Nordisk A/S, Bagsvaerd, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical and Science, GLP-1, Novo Nordisk A/S, Bagsvaerd, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060585389","display_name":"Tomoyuki Nishida","orcid":"https://orcid.org/0009-0004-5812-7167","observed_orcids":["https://orcid.org/0009-0004-5812-7167"]},"institutions":[{"id":"https://openalex.org/I4405265707","display_name":"Novo Nordisk Pharma Ltd. (Japan)","ror":"https://ror.org/05gzvb546","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405265707"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoyuki Nishida","raw_affiliation_strings":["Novo Nordisk Pharma Ltd, Tokyo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk Pharma Ltd, Tokyo","institution_ids":["https://openalex.org/I4405265707"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052412166","display_name":"Yutaka Seino","orcid":"https://orcid.org/0000-0002-1099-7989","observed_orcids":["https://orcid.org/0000-0002-1099-7989"]},"institutions":[{"id":"https://openalex.org/I2800996768","display_name":"Kansai Electric Power (Japan)","ror":"https://ror.org/03xrg8731","country_code":"JP","type":"company","lineage":["https://openalex.org/I2800996768"]},{"id":"https://openalex.org/I4210123101","display_name":"Kansai Electric Power Hospital","ror":"https://ror.org/02srt1z47","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210123101"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yutaka Seino","raw_affiliation_strings":["Kansai Electric Power Hospital, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kansai Electric Power Hospital, Osaka, Japan","institution_ids":["https://openalex.org/I2800996768","https://openalex.org/I4210123101"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5036190568"],"corresponding_institution_ids":["https://openalex.org/I189996419"],"apc_list":{"value":3850,"currency":"USD","value_usd":3850},"apc_paid":null,"fwci":3.4919,"has_fulltext":true,"cited_by_count":49,"citation_normalized_percentile":{"value":0.92192992,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"2","issue":"6","first_page":"441","last_page":"447"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9829999804496765},{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9869999885559082},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8579999804496765},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.8619999885559082},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9430000185966492},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9430000185966492},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.8889999985694885},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.8949999809265137},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.7319999933242798},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8560000061988831},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9390000104904175},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.6380000114440918},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.49900001287460327},{"id":"https://openalex.org/keywords/uncontrolled-diabetes","display_name":"uncontrolled diabetes","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.9895414113998413},{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.931338906288147},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8928209543228149},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7019830942153931},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6161117553710938},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.6106641292572021},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5800101161003113},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5143715143203735},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4800068736076355},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.43689724802970886},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3647879362106323}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1111/j.2040-1124.2011.00128.x","doi":"https://doi.org/10.1111/j.2040-1124.2011.00128.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.2040-1124.2011.00128.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.2040-1124.2011.00128.x","source":{"id":"https://openalex.org/S107365432","display_name":"Journal of Diabetes Investigation","issn_l":"2040-1116","issn":["2040-1116","2040-1124"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310322041","host_organization_name":"Asian Association for the Study of Diabetes","host_organization_lineage":["https://openalex.org/P4310322041"],"host_organization_lineage_names":["Asian Association for the Study of Diabetes"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Diabetes Investigation","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3001357","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4014903","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:24843528","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24843528","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of diabetes investigation","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4014903","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4014903/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Diabetes Investig","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/j.2040-1124.2011.00128.x","doi":"https://doi.org/10.1111/j.2040-1124.2011.00128.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.2040-1124.2011.00128.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.2040-1124.2011.00128.x","source":{"id":"https://openalex.org/S107365432","display_name":"Journal of Diabetes Investigation","issn_l":"2040-1116","issn":["2040-1116","2040-1124"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310322041","host_organization_name":"Asian Association for the Study of Diabetes","host_organization_lineage":["https://openalex.org/P4310322041"],"host_organization_lineage_names":["Asian Association for the Study of Diabetes"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Diabetes Investigation","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320333876","display_name":"Novo Nordisk Pharma","ror":"https://ror.org/05gzvb546"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1483095253.pdf","grobid_xml":"https://content.openalex.org/works/W1483095253.grobid-xml"},"referenced_works_count":18,"referenced_works":["https://openalex.org/W1975756049","https://openalex.org/W1977119153","https://openalex.org/W2004409542","https://openalex.org/W2012425163","https://openalex.org/W2013851956","https://openalex.org/W2043092889","https://openalex.org/W2053138570","https://openalex.org/W2058922633","https://openalex.org/W2063715420","https://openalex.org/W2068488844","https://openalex.org/W2071835038","https://openalex.org/W2078089300","https://openalex.org/W2098459806","https://openalex.org/W2102400698","https://openalex.org/W2126520659","https://openalex.org/W2141338760","https://openalex.org/W2152835319","https://openalex.org/W4254695749"],"related_works":["https://openalex.org/W2012425163","https://openalex.org/W2312778649","https://openalex.org/W1977119153","https://openalex.org/W2325198396","https://openalex.org/W3030815835","https://openalex.org/W2335557701","https://openalex.org/W3031548469","https://openalex.org/W2138290933","https://openalex.org/W2137352234","https://openalex.org/W1559082056"],"abstract_inverted_index":{"UNLABELLED:":[0],"Aims/Introduction:":[1],"We":[2],"compared":[3,250],"the":[4,53,90,113,116,126,175,186,195,210],"safety":[5,248],"and":[6,78,92,101,128,142,153,159,166,189,212,217,247],"efficacy":[7],"of":[8,63,115,144,200,235],"liraglutide":[9,42,91,127,176,187,211,236,255],"vs":[10,86],"glibenclamide":[11,38,71,93,129,196,213,261],"in":[12,89,174,185,194,209,224],"patients":[13,65,201],"with":[14,37,251,268],"poorly":[15],"controlled":[16],"(HbA1c,":[17],"7.4-10.4%)":[18],"type":[19],"2":[20],"diabetes.":[21],"MATERIALS":[22],"AND":[23],"METHODS:":[24],"Subjects":[25],"were":[26,50,58,76,172,222],"randomly":[27],"assigned":[28],"at":[29,112,203],"a":[30],"1:2":[31],"ratio":[32],"to":[33,80,99,104,123,157],"receive":[34],"1-year":[35],"treatment":[36],"1.25-2.5":[39],"mg/day":[40],"or":[41],"0.9":[43,237],"mg/day.":[44],"Other":[45],"oral":[46],"anti-diabetic":[47],"drugs":[48],"(OAD)":[49],"prohibited":[51],"during":[52],"trial.":[54],"Adverse":[55],"events":[56],"(AE)":[57],"monitored.":[59],"RESULTS:":[60],"A":[61],"total":[62],"400":[64],"(liraglutide":[66,109],"group,":[67,72],"n":[68,73],"=":[69,74],"268;":[70],"132)":[75],"randomized":[77],"exposed":[79],"trial":[81,265],"products.":[82],"At":[83],"week":[84],"52":[85,240],"baseline,":[87],"HbA1c":[88,135],"groups":[94,214],"was":[95,118,138,180,215,230,266],"reduced":[96,181],"from":[97,102,151],"9.3":[98],"7.8%":[100],"9.2":[103],"8.2%,":[105],"respectively.":[106,146,162,219],"Treatment":[107],"difference":[108],"-":[110],"glibenclamide)":[111],"end":[114],"study":[117],"-0.49":[119],"(95%":[120],"CI,":[121],"-0.71":[122],"-0.27).":[124],"In":[125],"groups,":[130],"Japan":[131],"Diabetes":[132,273],"Society":[133],"target":[134],"<":[136],"6.9%":[137],"achieved":[139],"by":[140,182,191],"22.1":[141],"8.5%":[143],"patients,":[145],"Fasting":[147],"plasma":[148,164,169],"glucose":[149,165,170],"fell":[150],"202.8":[152],"202.1":[154],"mg/dL,":[155,161],"respectively,":[156],"145.3":[158],"156.7":[160],"Mean":[163,178],"mean":[167],"postprandial":[168],"increment":[171],"lower":[173],"group.":[177,197],"bodyweight":[179],"-0.8":[183],"kg":[184,193],"group":[188],"increased":[190],"1.0":[192],"The":[198],"proportion":[199],"reporting":[202],"least":[204],"one":[205],"treatment-emergent":[206],"AE":[207],"(TEAE)":[208],"91.4":[216],"91.7%,":[218],"Most":[220],"TEAE":[221],"mild":[223],"severity.":[225],"No":[226],"major":[227],"hypoglycemic":[228],"episode":[229],"observed.":[231],"CONCLUSIONS:":[232],"Once-daily":[233],"administration":[234],"mg":[238],"for":[239],"weeks":[241],"provides":[242],"more":[243],"favorable":[244],"metabolic":[245],"control":[246],"profile":[249],"glibenclamide.":[252],"Patients":[253],"on":[254,260],"lost":[256],"bodyweight,":[257],"whereas":[258],"those":[259],"gained":[262],"weight.":[263],"This":[264],"registered":[267],"ClinicalTrial.gov":[269],"(no.":[270],"NCT00393718).":[271],"(J":[272],"Invest,":[274],"doi:":[275],"10.1111/j.2040-1124.2011.00128.x,":[276],"2011).":[277]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}